FDA Grants Priority Review and EMA Accepts Regulatory Submission for Pfizer's Abrocitinib, an Oral Once-Daily JAK1 Inhibitor, for Patients 12 and Up with Moderate to Severe Atopic Dermatitis Pharmaceutical Investing
Cytiva strengthens support to diagnostics industry with new labs, services and supply chain enhancements Medical Device Investing
Medtronic Venous Stent Receives U.S. FDA Approval to Treat Venous Outflow Obstruction Medical Device Investing
/R E P E A T -- Sirona Biochem Announces Acceptance of Clinical Study for TFC-1067 in the Journal of Cosmetic Dermatology/ Biotech Investing
Seelos Therapeutics Announces Issuance of Composition of Matter Patent for SLS-007 Psychedelics Investing
Decreases in Americans' Primary Care Visits May Lead to Late Diagnoses of Potentially Serious Conditions1 Biotech Investing
